NSE is currently the most reliable tumor marker in the prognosis of lung cancer evolution, and is recognized as a helpful tool for the differential diagnosis of SCLC and NSCLC [38,39]. The gene discussed is ENO2; the disease is non-small cell lung carcinoma.